CORTEVA INC (CTVA)
Sector: Materials
2026 Annual Meeting Analysis
CORTEVA INC · Meeting: April 28, 2026
Directors FOR
12
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Directors
Director since June 2019 with strong chemical industry CEO experience; CTVA's 3-year return of +40.4% outpaces XLB by +12.6pp, well below the 65pp threshold required to trigger a performance-based AGAINST vote; no overboarding, attendance, or independence concerns.
Director since March 2021 with deep agriculture industry expertise from a career at Deere & Company; holds 2 outside public board seats (Brunswick, Allison Transmission), within the 4-seat limit for non-executive directors; TSR trigger does not apply given CTVA's strong outperformance relative to XLB.
Director since March 2021 with relevant agricultural and chemical industry background and governance experience; holds 1 public board seat (Twin Disc); no overboarding, attendance, or independence issues; TSR trigger does not fire.
New nominee and current CEO of Westlake Corporation with extensive specialty chemical CEO experience; as a sitting CEO he holds 1 outside public board seat (Corteva, if elected), within the 2-seat limit for sitting CEOs; exempt from TSR trigger as a new nominee.
Director since March 2021 with strong financial and investment management background; holds 1 outside public board seat (Toll Brothers); serves on Audit Committee with appropriate financial expertise (CFA designation); TSR trigger does not apply.
Director since June 2019 with relevant agribusiness and capital markets experience; currently holds 2 outside public board seats (Hidrovias do Brasil, Itau Unibanco), within the 4-seat limit; TSR trigger does not fire given CTVA's strong relative performance versus XLB.
CEO and director since November 2021 with over 20 years of agricultural and chemical industry experience; holds 1 outside public board seat (Ingredion), within the 2-seat limit for sitting CEOs; TSR trigger does not apply as CTVA's 3-year outperformance vs. XLB (+12.6pp) is well below the 65pp threshold.
Director since February 2020 with technology, cybersecurity, and AI expertise valuable to an innovation-driven agriculture company; holds 1 outside public board seat (TD SYNNEX); TSR trigger does not apply; no independence or attendance concerns.
Director since June 2019 and independent Board Chair with deep agriculture industry expertise as former Cargill CEO; holds 2 outside public board seats (Eaton, Deere), within the 4-seat limit; TSR trigger does not fire; strong financial expertise confirmed (audit committee financial expert).
New nominee with extensive agricultural cooperative and food industry leadership experience as former CEO of Land O'Lakes; holds 1 outside public board seat (Hormel Foods); exempt from TSR trigger as a new nominee; no governance concerns.
Director since March 2021 with deep agricultural and chemical industry expertise from a career at Monsanto; holds 1 outside public board seat (Avient Corporation); chairs the People and Compensation Committee; TSR trigger does not apply.
Director since June 2019 with strong financial expertise as former CFO of Cummins Inc.; holds 2 outside public board seats (Flex, Solstice Advanced Materials), within the 4-seat limit; chairs the Audit Committee and is designated an audit committee financial expert; TSR trigger does not fire.
All 12 director nominees receive a FOR vote. CTVA's 3-year price return of +40.4% outperforms the sector benchmark XLB by +12.6 percentage points, far below the 65pp threshold required to trigger performance-based AGAINST votes for directors serving during a period of strong positive absolute returns. No nominees are overboarded, no attendance issues were disclosed, all committee members are independent, and the board discloses a comprehensive skills matrix. Two new nominees (Gilson, Policinski) replace retiring directors and are exempt from the TSR trigger as new nominees.
Say on Pay
✓ FORCEO
Charles V. Magro
Total Comp
$17,499,399
Prior Support
89%%
The prior year say-on-pay vote received approximately 89% support, well above the 70% threshold that would require a negative response, and the company engaged actively with shareholders representing 48% of outstanding shares. The compensation program is heavily performance-based — 91% of the CEO's total direct compensation is at risk — with long-term incentives using multi-year metrics such as return on net assets and cumulative operating earnings-per-share growth, supplemented by a sustainability modifier in the short-term plan. The company discloses a comprehensive clawback policy covering both cash and equity, stock ownership requirements are rigorous, and CEO total compensation of approximately $17.5 million is consistent with the scale and performance of a $52 billion global agriculture technology company.
Auditor Ratification
✓ FORAuditor
PricewaterhouseCoopers LLP
Tenure
N/A
Audit Fees
N/A
Non-Audit Fees
N/A
PricewaterhouseCoopers is a Big 4 firm appropriate for a company of Corteva's size and complexity; the proxy does not provide a fee breakdown table with extractable dollar figures in the truncated text provided, so the non-audit fee ratio trigger cannot be confirmed to have fired; tenure is not explicitly disclosed in the provided text so that trigger does not apply per policy; no material restatements are disclosed, and the Audit Committee confirms all services were pre-approved in accordance with its pre-approval policy.
Overall Assessment
Corteva's 2026 annual meeting presents a clean ballot with no material governance concerns: all 12 director nominees receive FOR votes supported by strong relative stock performance versus the XLB benchmark, a well-qualified and substantially independent board, and a rigorous skills matrix. The executive compensation program is heavily performance-linked with 91% of CEO pay at risk, prior shareholder support of 89%, and a comprehensive clawback policy, warranting a FOR vote on say-on-pay; auditor ratification of PricewaterhouseCoopers is also supported as a Big 4 firm appropriate for a company of Corteva's size with proper pre-approval procedures in place.